PMID: 26775484Jan 19, 2016Paper

Potency Material Bases of Xuebijing Formula and Its Multi-target Effects on Sepsis

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
Shi-tang MaYou-yi Xiong

Abstract

To explore potency material bases of Xuebijing (XBJ) formula, and to analyze its effects at the molecular network level. Totally 16 sepsis-related targets were selected and classified into three categories such as inflammation, immune, and coagulation referring to biological roles. Then molecular database of chemical compositions in XBJ formula were constructed to explore mutual actions with inflammation, immune, and coagulation targets. Danshen root and safflower, with more effector molecules with immune and coagulation targets, have extensive anticoagulation and anti-inflammation effects. The former 10 molecules with better mutual actions with sepsis targets were sequenced as tryptophane, danshensu, gallic acid, salvianolic acid D, protocatechuic acid, salvianolic acid A, danshensu C, vanillic acid, rosmarinic acid, phenylalanine. There existed two phenomena in XBJ formula as follows. One component had stronger actions with multi-targets, for example, danshensu had actions with 13 targets. Meanwhile, different components acted on the same target protein, for example, 8 molecules acted with MD-2. XBJ formula had certain potential synergistic effects with sepsis targets, which could provide certain referential roles for findina...Continue Reading

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Mikrobiologicheskiĭ zhurnal
S S DIACHENKO, P Ia POCHINOK
Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns
H JiangD Wei
© 2022 Meta ULC. All rights reserved